Evidence map›Paper›PMID 41979352›Full record

ArticlemBio2026

Harnessing random peptide mixtures to combat multidrug-resistant fungal infections.

John Adeoye, Yael Belo, Marina Campos Rocha, Hilla Hayby, Aygun Israyilova, Zvi Hayouka, Neta Shlezinger

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

John Adeoye *Koret School of Veterinary Medicine, Faculty of Agriculture, The Hebrew University, Rehovot, Israel.ORCID 0000-0003-0621-4889
Yael Belo *Institute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agricultural, Food & Environment, The Hebrew University of Jerusalem, Rehovot, Israel.
Marina Campos RochaKoret School of Veterinary Medicine, Faculty of Agriculture, The Hebrew University, Rehovot, Israel.
Hilla HaybyKoret School of Veterinary Medicine, Faculty of Agriculture, The Hebrew University, Rehovot, Israel.
Aygun IsrayilovaLaboratory of Microbiology, Center for Excellence in Research, Development & Innovation, Baku State University, Baku, Azerbaijan.
Zvi HayoukaInstitute of Biochemistry, Food Science and Nutrition, The Robert H. Smith Faculty of Agricultural, Food & Environment, The Hebrew University of Jerusalem, Rehovot, Israel.ORCID 0000-0003-3582-4029
Neta ShlezingerKoret School of Veterinary Medicine, Faculty of Agriculture, The Hebrew University, Rehovot, Israel.ORCID 0000-0003-0005-0756

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive fungal infections are associated with high mortality and are increasingly difficult to treat due to a limited antifungal arsenal and the rapid emergence of drug resistance. Novel therapeutic strategies that combine potent antifungal activity, low host toxicity, IMPORTANCE: The rising prevalence of invasive fungal infections, particularly among immunocompromised individuals, has become a critical public health concern. However, antifungal drug development has not kept pace with this growing need, and treatment options remain limited to a small number of drug classes. The emergence of multidrug-resistant fungal pathogens, such as

Indexed as

Antifungal AgentsAntimicrobial PeptidesDrug Resistance, Multiple, FungalAnimalsAspergillus fumigatusBiofilmsCandidaCandida aurisCandidiasisCryptococcus neoformansDisease Models, AnimalFemaleHumansMiceMicrobial Sensitivity TestsAntifungal AgentsAntimicrobial PeptidesAMPsAMRantifungalsCandida auriscandidiasis

Identifiers

PMID41979352
PMCPMC13170328

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.